LeonaBio, Inc. (LONA)
NASDAQ: LONA · Real-Time Price · USD
7.04
+0.07 (1.00%)
Jul 29, 2026, 4:00 PM EDT - Market closed

LeonaBio Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Income
-109.94-102.27-100.9-125.47-104.02-64.02
Net Income
-129.41-105.61-96.94-117.67-95.64-54.85
Earnings Per Share
-24.11-24.70-25.19-30.90-25.30-14.90
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
67.6888.3351.28147.42200.34253.76
Total Debt
0.690.81.221.591.911.92
Net Cash (Debt)
66.9987.5350.06145.83198.43251.84
Net Cash Growth
88.42%74.85%-65.67%-26.51%-21.21%37.11%
Net Cash Per Share
8.3120.4713.0138.3652.5968.21

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-51.97-45.73-97.17-100.75-72.47-43.1
Capital Expenditures
---0.03-0.3-1.14-1.57
Free Cash Flow
-51.97-45.73-97.2-101.06-73.61-44.67
Free Cash Flow Growth
------

Valuation

Selected indicators aren't available for this stock.